JP Morgan Chase
IMCR icon

JP Morgan Chase’s Immunocore IMCR Stock Holding History

JP Morgan Chase’s Portfolio IMCR Stock Details IMCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-5,600
Closed -$364K – 7552
2024
Q1 		$364K Buy
5,600
+3,100
+124% +$213K ﹤0.01% 4999
2023
Q4 		$171K Buy
2,500
+1,400
+127% +$72.8K ﹤0.01% 5477
2023
Q3 		$57.1K Sell
1,100
-18,700
-94% -$1.11M ﹤0.01% 5752
2023
Q2 		$1.19M Buy
+19,800
New +$1.13M ﹤0.01% 3922

Other funds holding IMCR

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

JP Morgan Chase's IMCR Position: Q1 2026 in Review

JP Morgan Chase reduced its Immunocore (IMCR) stake by 4.8% in Q1 2026, selling an estimated $5.76K and leaving 3,521 shares worth $103K. The position accounts for ﹤0.01% of the portfolio, ranked #5816.

JP Morgan Chase first reported a position in IMCR in Q2 2022 and has held it in 16 quarters since. The position peaked at $6.91M in Q4 2023. 142 funds tracked by Wall St. Rank hold IMCR as of Q1 2026.

  • JP Morgan Chase held 3,521 shares of Immunocore worth $103K as of Q1 2026.
  • JP Morgan Chase sold 178 Immunocore shares in Q1 2026, an estimated $5.76K.
  • Immunocore made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #5816 holding.
  • JP Morgan Chase first reported a position in Immunocore in Q2 2022 and has held it in 16 quarters since.
  • JP Morgan Chase's Immunocore position peaked at $6.91M in Q4 2023.
  • 142 funds tracked by Wall St. Rank held Immunocore as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.